- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02925585
Vaginal Tactile Imaging for Pelvic Floor Prolapse
March 20, 2019 updated by: Artann Laboratories
Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.
Study Overview
Study Type
Observational
Enrollment (Actual)
119
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- The Pelvic Floor Institute
-
-
New Jersey
-
Princeton, New Jersey, United States, 08540
- Princeton Urogynecology PU
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18103
- The Institute for Female Pelvic Medicine and Reconstructive Surgery
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Inova Health System Foundation
-
Norfolk, Virginia, United States, 23501
- Eastern Virginia Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients scheduled for pelvic floor surgery
Description
Inclusion Criteria:
- Subject is female of 21 years or older, and
- No prior pelvic floor surgery, and
- One of the following:
Normal pelvic floor conditions, or POP Stage I affecting one or more vaginal compartment, or POP Stage II affecting one or more vaginal compartment, or POP Stage III affecting one or more vaginal compartment, or POP Stage IV affecting one or more vaginal compartment
Exclusion Criteria:
- Active skin infection or ulceration within the vagina
- Presence of a vaginal septum;
- Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
- Ongoing radiation therapy for pelvic cancer;
- Impacted stool;
- Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvadynia;
- Severe hemorrhoids;
- Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician;
- Current pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pre/post pelvic floor surgery imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tissue elasticity change after the surgery measured as a gradient in tactile image. Unit of measure: mmHg/mm
Time Frame: pre-surgery and post-surgery (4-6 months after surgery) measurements
|
Tissue elasticity is measured for entire anterior and posterior compartments
|
pre-surgery and post-surgery (4-6 months after surgery) measurements
|
|
Pelvic floor muscle strength change after the surgery measured as a pressure dynamic feedback during muscle contractions. Unit of measure: mmHg
Time Frame: pre-surgery and post-surgery (4-6 months after surgery) measurements
|
Muscle strength is measured during voluntary and involuntary muscle contractions, involuntary relaxation and Valsalva maneuver.
|
pre-surgery and post-surgery (4-6 months after surgery) measurements
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
October 3, 2016
First Submitted That Met QC Criteria
October 4, 2016
First Posted (Estimate)
October 6, 2016
Study Record Updates
Last Update Posted (Actual)
March 21, 2019
Last Update Submitted That Met QC Criteria
March 20, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VTI09
- SB1AG034714 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Scientific Publications of the study results
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.